[Abu Sin, M., Takla, A., Flieger, A., Prager, R., Fruth, A., Tietze, E., Fink, E., Korte, J., Schink, S., Höhle, M, Eckmans, T. (2012). Carrier prevalence, secondary household transmission, and long-term shedding in 2 districts during the Escherichia Coli O104:H4 outbreak in Germany, 2011. J. Infec. Dis., 207 (3), 432–438.]Search in Google Scholar
[Adams, N., Byrne, L., Rose, T., Adak, B., Jenkins, C., Charlett, A., Hawker, J. (2019). Sociodemographic and clinical risk factors for paediatric typical haemolytic uraemic syndrome: Retrospective cohort study. BMJ Paediatr. Open, 3 (1), e000465.10.1136/bmjpo-2019-000465693698831909217]Search in Google Scholar
[Anonymous (2020). Seegene AllplexTM GI-Bacteria(II) Assay. http://www.seegene.com/assays/allplex_gi_bacteria_ii_assay (accessed 17.01.2020).]Search in Google Scholar
[Bashir, M. E., Louie, S., Shi, H. N., Nagler-Anderson, C. (2004). Toll-like receptor 4 signaling by intestinal microbes influences susceptibility to food allergy. J. Immunol., 172 (11), 6978–6987.10.4049/jimmunol.172.11.697815153518]Search in Google Scholar
[Brown, M. E., Arrieta, M.-C.,Finlay, B. B. (2013). A fresh look at the hygiene hypothesis: How intestinal microbial exposure drives immune effector responses in atopic disease. Seminars Immunol., 25 (5), 378–387.10.1016/j.smim.2013.09.00324209708]Search in Google Scholar
[Croxen, M. A., Law, R. J., Scholz, R., Keeney, K. M., Wlodarska, M., Finlay B. B. (2013). Recent advances in understanding enteric pathogenic Escherichia coli. Clin. Microbiol. Rev., 26 (4), 822–880.10.1128/CMR.00022-13381123324092857]Search in Google Scholar
[Fujimura, K. E., Lynch S. V. (2015). Microbiota in allergy and asthma and the emerging relationship with the gut microbiome. Cell Host Microbe, 17 (5), 592–602.10.1016/j.chom.2015.04.007444381725974301]Search in Google Scholar
[Garth, J., Barnes, J. W., Krick S. (2018). Targeting cytokines as evolving treatment strategies in chronic inflammatory airway diseases. Int. J. Mol. Sci., 19 (11), 3402.10.3390/ijms19113402627501230380761]Search in Google Scholar
[Hu, J., Torres, A. G. (2015). Enteropathogenic Escherichia coli: Foe or innocent bystander? Clin. Microbiol. Infect., 21 (8), 729–734.10.1016/j.cmi.2015.01.015449794225726041]Search in Google Scholar
[Nataro, J. P., Mai, V., Johnson, J., Blackwelder, W. C., Heimer, R., Tirrell, S., Edberg, S. C., Braden, C. R., Morris, J. G., Jr., Hirshon, J. M. (2006). Diarrheagenic Escherichia coli infection in Baltimore, Maryland, and New Haven, Connecticut. Clin. Infect. Dis., 43 (4), 402–407.10.1086/50586716838226]Search in Google Scholar
[Lima, F. M., Daurelio, F. de P., Mucci, E. R., Ahagon, C. M., dos Santos Carmo, A. M., Eterovic, A., dos Santos, L. F., Tiba-Casas, M. R., Camargo, C. H., Cergole-Novella, M. C. (2019). Epidemiology and genetic screening of diarrheagenic Escherichia coli among symptomatic and asymptomatic children. J. Med. Microbiol., 68 (7), 1033–1041.10.1099/jmm.0.00102031199225]Search in Google Scholar
[Manthey Carolin, F., Chloe, A. Autran, L. E., Bode, L. (2014). Human milk oligosaccharides protect against enteropathogenic Escherichia coli attachment in vitro and pathogenic E. coli colonization in suckling mice. J. Pediatr. Gastroenterol. Nutr., 58 (2), 165–168.]Search in Google Scholar
[Mathew, S., Smatti, M. K., Al Ansari, K., Nasrallah, G. K., Thani, A. A., Yassine, H. M. (2019). Mixed viral-bacterial infections and their effects on gut microbiota and clinical illnesses in children. Scientific Reports, 9 (865).10.1038/s41598-018-37162-w635154930696865]Search in Google Scholar
[Nataro, J. P., Kaper, J. B. (1998). Diarrheagenic Escherichia coli. Clin. Microbiol. Rev., 11 (1), 142–201.10.1128/CMR.11.1.1421213799457432]Search in Google Scholar
[Ramya Raghavan, P., Subarna K. R., Ramanathan T., Suguna, A. P. (2017). Diarrheagenic Escherichia coli infections among the children of Andaman Islands with special reference to pathotype distribution and clinical profile. J. Epidemiol. Global Health, 7 (4).]Search in Google Scholar
[Remko Enserink, R., Scholts, R., Bruijning-Verhagen, P., Duizer, E., Vennema, H., de Boer, R., Kortbeek, T., Roelfsema, J., Smit, H., Kooistra-Smid, M., van Pelt, W. (2014). High detection rates of enteropathogens in asymptomatic children attending day care. Plos One, 9 (2).10.1371/journal.pone.0089496393354224586825]Search in Google Scholar
[Ruchaud-Sparagano, M. H., Maresca, M., Kenny B. (2007). Enteropathogenic Escherichia coli (EPEC) inactivate innate immune responses prior to compromising epithelial barrier function. Cell. Microbiol., 9 (8), 1909–1921.10.1111/j.1462-5822.2007.00923.x197480517388785]Search in Google Scholar
[Sabharwal, H., Cichon, C., Ölschläger, T. A., Sonnenborn, U., Schmidt M. A. (2016). Interleukin-8, CXCL1, and microRNA miR-146a responses to probiotic Escherichia coli Nissle 1917 and enteropathogenic E. coli in human intestinal epithelial T84 and monocytic THP-1 cells after apical or basolateral infection. Infect. Immun., 84 (9), 2482–2492.]Search in Google Scholar
[Spano, L. C., da Cunha, K. F., Monfardini, M. V., de Cassia Bergamaschi Fonseca, R., Scaletsky, I. C. A. (2017). High prevalence of diarrhea-genic Escherichia coli carrying toxin-encoding genes isolated from children and adults in southeastern Brazil ‘Results’. BMC Infect. Dis., 17, 773.10.1186/s12879-017-2872-0573557729254489]Search in Google Scholar
[Wesemann, D. R., Nagler, C. R. (2016). The microbiome, timing, and barrier function in the context of allergic disease. Immunity, 44 (4), 728–738.10.1016/j.immuni.2016.02.002486996427096316]Search in Google Scholar